Other languages Third Harmonic Bio, Inc.

Equities

THRD

US88427A1079

Market Closed - Nasdaq Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
13 ^USD	+1.40%		+5.01%	+18.51%

06-18	Stifel Initiates Third Harmonic Bio With Buy Rating, $23 Price Target	MT
06-07	Third Harmonic Bio, Inc. Announce Resignation of Rob Perez as a Class I Director of the Board, and as Chairperson of the Nominating and Governance Committee of the Board and A Member of the Audit Committee of the Board	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Third Harmonic Bio, Inc. Announce Resignation of Rob Perez as a Class I Director of the Board, and as Chairperson of the Nominating and Governance Committee of the Board and A Member of the Audit Committee of the Board	06-07
Third Harmonic Bio Insider Sold Shares Worth $331,066, According to a Recent SEC Filing	05-20
Third Harmonic Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15
Third Harmonic Bio, Inc. Announces the Appointment and Promotion of Key Executive Leaders to the Organization	05-15
Third Harmonic Bio, Inc. Appoints Geoff Mcdonough to Its Board of Directors	03-28
Third Harmonic Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26
Third Harmonic Bio Names Christopher Murphy as Chief Financial, Business Officer	01-04
Third Harmonic Bio, Inc. Appoints Christopher Murphy as Chief Business Officer	01-04
Third Harmonic Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Third Harmonic Bio, Inc. Announces the Transition of Adrian S. Ray from Chief Scientific Officer to Scientific Advisor, Effective November 1, 2023	31/10/23
Third Harmonic Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Third Harmonic Bio, Inc Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335	25/07/23
Third Harmonic Bio, Inc. Ratifies the Appointment of Deloitte & Touche LLP as the Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2023	08/06/23
Third Harmonic Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
Third Harmonic Bio, Inc. Announces Resignation of Shao-Lee Lin as Class II Director and Chairperson of the Nominating and Governance Committee of the Board	19/01/23
Top Midday Decliners	15/12/22
Sector Update: Health Care Stocks Sinking with Broader Thursday Markets	15/12/22
Sector Update: Health Care	15/12/22
Third Harmonic Bio Halts Phase 1b Trial of Proposed Treatment for Inflammatory Skin Condition; Shares Decline	15/12/22
Weaker-Than-Expected Retail Sales, Hawkish Fed Send US Stock Futures Sharply Lower	15/12/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Third Harmonic Bio, Inc.

Equities

THRD

US88427A1079

Other languages

Filters